Karl Pfleger
Overview
Karl Pfleger is an angel investor based in San Francisco, California, focusing on biotechnology and longevity startups. He is the founder of AgingBiotech.Info, a resource dedicated to providing structured information about aging and longevity. Through this platform, he aims to support the growth and development of companies in the longevity biotech sector. With a background in technology, Karl worked at Google from 2002 to 2013 as a research scientist and data analyst, applying AI and machine learning at scale. He holds a BSE in Computer Science from Princeton University and a PhD in Computer Science and AI from Stanford University. His technical expertise informs his investment decisions, particularly in the biotech sector. Karl's investment portfolio includes companies such as AgeX Therapeutics, Covalent Bioscience, Oisin BioTechnologies, Repair Biotechnologies, Retrotope, GTech Medical, Blumio, Sixfold Bioscience, Juvena Therapeutics, and Correlia Biosystems. His focus is on early to growth-stage companies in the biotechnology and longevity sectors, with investment sizes ranging from $100,000 to $5 million.
Reach Karl Pfleger directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Karl Pfleger
What sectors does Karl Pfleger invest in?
Karl Pfleger invests in Healthcare, Biotechnology, Longevity and Aging Research, and is based in California, United States. Karl Pfleger is listed as a angel investor in the ConnectSafely investor database.
What stage does Karl Pfleger invest at?
Karl Pfleger backs companies at Seed, Early Stage and Growth, writing cheques of 100K - 5M.
Which regions does Karl Pfleger invest in?
Karl Pfleger invests across United States.
Last updated · Source: ConnectSafely investor database